Aubin Gael*
The emergence of antibiotic-resistant bacteria poses a significant challenge to public health worldwide. Vancomycin, a potent antibiotic, is often used as a last resort for treating infections caused by such bacteria. However, the monitoring of vancomycin levels in patients' blood is crucial to ensure its therapeutic efficacy and prevent toxicity. In this article, we delve into the development and application of a one-step lateral flow immunoassay for the rapid and efficient detection of vancomycin in whole blood samples. We discuss the principles behind the assay, its advantages over traditional methods, and its potential implications for clinical practice.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 